Caitlin Cronin
Stock Analyst at Canaccord Genuity
(3.21)
# 671
Out of 4,778 analysts
24
Total ratings
36.84%
Success rate
7.55%
Average return
Main Sectors:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TELA TELA Bio | Maintains: Buy | $12 → $7 | $1.23 | +469.11% | 4 | Mar 21, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $28.44 | -5.06% | 1 | Mar 17, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $9.44 | +58.90% | 1 | Mar 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $22 → $26 | $18.99 | +36.91% | 4 | Feb 26, 2025 | |
| VCEL Vericel | Maintains: Buy | $64 → $67 | $47.96 | +39.70% | 3 | Feb 3, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $3 → $4 | $2.76 | +44.93% | 2 | Nov 14, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 | $10.32 | +93.80% | 3 | Aug 30, 2024 | |
| INMD InMode | Maintains: Hold | $21 → $16 | $18.43 | -13.19% | 2 | Jul 12, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $110.37 | +17.79% | 1 | Feb 23, 2024 | |
| ENOV Enovis | Maintains: Buy | $73 → $75 | $39.41 | +90.31% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $79 | $76.62 | +3.11% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $7.33 | +63.71% | 1 | Nov 14, 2023 |
TELA Bio
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $7
Current: $1.23
Upside: +469.11%
Smith & Nephew
Mar 17, 2025
Maintains: Hold
Price Target: $27
Current: $28.44
Upside: -5.06%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $9.44
Upside: +58.90%
Axogen
Feb 26, 2025
Maintains: Buy
Price Target: $22 → $26
Current: $18.99
Upside: +36.91%
Vericel
Feb 3, 2025
Maintains: Buy
Price Target: $64 → $67
Current: $47.96
Upside: +39.70%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.76
Upside: +44.93%
Alphatec Holdings
Aug 30, 2024
Maintains: Buy
Price Target: $20
Current: $10.32
Upside: +93.80%
InMode
Jul 12, 2024
Maintains: Hold
Price Target: $21 → $16
Current: $18.43
Upside: -13.19%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $110.37
Upside: +17.79%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $39.41
Upside: +90.31%
Feb 21, 2024
Reiterates: Buy
Price Target: $79
Current: $76.62
Upside: +3.11%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $7.33
Upside: +63.71%